







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2013-01-23 | Buy | 39,600 | $19.78 | 783.3 | 41.61 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2012-12-14 | Buy | 5,386 | $18.63 | 100.3 | 50.35 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2012-12-06 | Buy | 50,100 | $17.94 | 898.8 | 56.13 | 0.00 | 2565.70 | 540.071 | |
![]() | TRGT | Targacept, Inc. | BVF PARTNERS L P/IL | 10% Owner | 2012-11-16 | Buy | 595,000 | $4 | 2380 | 37 | 0.00 | 138.70 | 181.877 | |
![]() | TRGT | Targacept, Inc. | BVF PARTNERS L P/IL | 10% Owner | 2012-11-16 | Buy | 1,290,212 | $4.06 | 5238.3 | 34.98 | 0.00 | 138.70 | 181.877 | |
![]() | CCXI | Chemocentryx In... | BVF PARTNERS L P/IL | 10% Owner | 2012-11-06 | Buy | 40,000 | $12 | 480 | 13.42 | 0.00 | 0.00 | 586.858 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2012-10-31 | Buy | 16,591 | $15.19 | 252 | 84.4 | 0.00 | 2565.70 | 540.071 | |
![]() | TRGT | Targacept, Inc. | BVF PARTNERS L P/IL | 10% Owner | 2012-11-08 | Buy | 72,429 | $4.03 | 291.9 | 35.98 | 0.00 | 138.70 | 181.877 | |
![]() | CCXI | Chemocentryx In... | BVF PARTNERS L P/IL | 10% Owner | 2012-11-06 | Buy | 40,000 | $12 | 480 | 13.42 | 0.00 | 0.00 | 586.858 | |
![]() | TRGT | Targacept, Inc. | BVF PARTNERS L P/IL | 10% Owner | 2012-11-02 | Buy | 139,700 | $4.05 | 565.8 | 35.31 | 0.00 | 138.70 | 181.877 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2012-10-31 | Buy | 16,591 | $15.19 | 252 | 84.4 | 0.00 | 2565.70 | 540.071 | |
![]() | ARRY | Array BioPharma... | BVF PARTNERS L P/IL | 10% Owner | 2011-12-05 | Buy | 183,853 | $2.11 | 387.9 | 179.15 | 0.00 | 0.00 | 664.456 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-11-21 | Buy | 511,040 | $10.65 | 5442.6 | 163 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-26 | Buy | 6,020 | $13.91 | 83.7 | 101.37 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-21 | Buy | 4,600 | $13.93 | 64.1 | 101.08 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-20 | Buy | 14,100 | $13.9 | 196 | 101.51 | 0.00 | 2565.70 | 540.071 | |
![]() | NBIX | Neurocrine Bios... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-12 | Buy | 29,500 | $5.96 | 175.8 | 97.15 | 0.00 | 147.60 | 800.121 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-13 | Buy | 75,353 | $13.65 | 1028.6 | 105.2 | 0.00 | 2565.70 | 540.071 | |
![]() | NBIX | Neurocrine Bios... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-11 | Buy | 73,900 | $5.6 | 413.8 | 109.82 | 0.00 | 147.60 | 800.121 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-10-04 | Buy | 14,400 | $12.78 | 184 | 119.17 | 0.00 | 2565.70 | 540.071 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-09-06 | Buy | 312,900 | $0.26 | 81.4 | -19.23 | 0.00 | 0.00 | 7.35937 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-08-22 | Buy | 78,900 | $0.26 | 20.5 | -19.23 | 0.00 | 0.00 | 7.35937 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-08-19 | Buy | 37,871 | $11.92 | 451.4 | 134.98 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-08-11 | Buy | 1,394 | $11.19 | 15.6 | 150.31 | 0.00 | 2565.70 | 540.071 | |
![]() | LGND | Ligand Pharmace... | BVF PARTNERS L P/IL | 10% Owner | 2011-08-10 | Buy | 599,700 | $10.98 | 6584.7 | 155.1 | 0.00 | 2565.70 | 540.071 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-07-29 | Buy | 954,250 | $0.25 | 238.6 | -16 | 0.00 | 0.00 | 7.35937 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-07-26 | Buy | 18,400 | $0.25 | 4.6 | -16 | 0.00 | 0.00 | 7.35937 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-07-20 | Buy | 252,600 | $0.25 | 63.2 | -16 | 0.00 | 0.00 | 7.35937 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-07-18 | Buy | 358,600 | $0.25 | 89.7 | -16 | 0.00 | 0.00 | 7.35937 | |
![]() | CAPS | Capstone Therap... | BVF PARTNERS L P/IL | 10% Owner | 2011-06-30 | Buy | 4,700 | $0.25 | 1.2 | -16 | 0.00 | 0.00 | 7.35937 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Jim Simons | 2013-03-31 | 0 | 0% | Sold Out | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments